BioSpace News Archive

The Ivy Rehab Network, a national leader in outpatient musculoskeletal rehabilitative services, is proud to announce it has joined Cigna as an in-network provider in six states, effective May 17th.

Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to treat oncology indications, announced today that it was awarded a Small Business Innovative Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID)

Edwards Lifesciences announced that clinical results from the company’s transcatheter mitral and tricuspid programs were presented as part of the late-breaking clinical trials at EuroPCR 2021, demonstrating positive outcomes for patients impacted by mitral or tricuspid heart valve disease.

Edwards Lifesciences announced the results of a real-world study comparing outcomes for patients with bicuspid aortic stenosis who were treated with SAPIEN 3 and SAPIEN 3 Ultra Transcatheter Aortic Valve Replacement and at low risk of death from surgery.

Medpace Holdings, Inc. announced that it will present at the following investor conference

Dr. Connolly brings a commitment to diversity, equity, and inclusion as she leads the medical specialty society in 2021-22.

GeneThera is pleased to announce that it has incorporated a subsidiary in the United Kingdom. GeneThera Robotics Ltd, a majority owned subsidiary based in England, will be responsible for UK and International Operations.

Public Listing offers Access to CAD 52 Million from Share Subscription and Drawdown Agreement, Sufficient Funding to Complete Development and Launch Avisa BreathTest™ Pivotal Trials Planned in Post-COVID-19 Long Haulers and Ventilator-Associated Pneumonia

Aerovate Therapeutics, Inc. (Aerovate), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced the appointment of veteran biotechnology leader Timothy Noyes as Chief Executive Officer.

Elevation Oncology, a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, announced today the appointment of R. Michael Carruthers to its Board of Directors and Chair of the Audit Committee.